afforded by chemosensitive nociceptive neurons, which, when activated, drive adaptive behavioral responses. The repertoire of receptors identified on nociceptors continues to expand, and a major surprise of the current work is the identification of several irritants that activate TRPA1. These now include the pungent extracts from garlic, mustard oil, acrolein (an irritant from tear gas and car exhaust fumes), and the metabolic products from the chemotherapeutic agent cyclophosphamide. It is not established that TRPA1 binds all these irritants, so an indirect effect is a formal possibility. Although TRPs have traditionally been viewed (at least in somatosensation) as responding to distinct sensory stimuli (Figure 1 ), the work by Bautista et al. (2006) shows that multiple agents and mechanisms can lead to channel activation.
Perhaps an even more surprising finding is that nociceptor responses to bradykinin, a much-studied endogenous pain mediator, are largely attenuated in mice lacking either TRPA1 or TRPV1. This is unexpected because bradykinin is known to exert its actions via B2 receptors, which are also expressed by nociceptors. The data strongly suggest that ligands activating G protein-coupled receptors (GPCRs) coupled to phospholipase C-β (and these are numerous, including ATP at P2Y receptors, serotonin at its receptor, 5HT2a, and acetylcholine at muscarinic receptors) lead to a form of gating or transactivation of TRPA1. The inward current generated in TRP channels by this mechanism may thereby integrate different stimuli to a cell. The mutual dependence of bradykinin responses on both TRPA1 and TRPV1 might be explained by cumulative Ca 2+ entry from the two channels but might also indicate the importance of TRPA1/V1 heteromultimers ( Figure 1 ). It is well established that all DRG neurons that express TRPA1 also express TRPV1.
This work raises not only scientific but also organizational issues. As the Knockout Mouse Project at the NIH and the European Eurocomm programs move forward with the aim of deleting all mouse genes, how will their efforts to monitor mouse phenotypes keep pace? It seems doubtful that any of the active screens would pick up the interesting features of the TRPA1 knockout mouse. Secondly, like other TRP channels, the principal physiological role of TRPA1 remains obscure. Although TRPA1 is activated by tear gas and other exogenous irritants, it seems likely that endogenous activators also exist. After the heroic studies using expression cloning that have provided so much information about TRPs, we can now expect an equivalent effort in the expression cloning and purification of ligands, which should further illuminate the physiological roles of these remarkable channels.
to the nonpermissive temperature, the temperature-sensitive cdc13-1 mutant experiences extensive degradation of chromosome 5′ ends (dependent on the nuclease Exo1) that is followed by a RAD9-dependent G2/M checkpoint arrest (Garvik et al., 1995) . As a consequence, deletion of RAD9 (in addition to other checkpoint genes) or EXO1 partially suppress the growth defect of cdc13-1.
This was the starting point for Downey et al. (2006) , who searched for new genes involved in capping by asking whether other yeast genes, when mutated, would suppress the growth defect of cdc13-1. To do this they crossed the cdc13-1 mutant to a collection of ?4800 strains with nonessential gene deletions, after which haploid double mutant meiotic segregants were selected. This genome-wide screen identified most of the known suppressors of cdc13-1. These include rad9 and other checkpoint mutants, as well as three genes involved in nonsense-mediated decay, which act by increasing the cellular levels of Stn1, thus partially restoring function to a weakened cdc13-1 protein. Five novel suppressors were also found, one of which was a previously uncharacterized gene (YML036). Downey et al. (2006) decided to further characterize this gene, in part because it encodes a highly conserved protein, whose closest human relative, CGI-121, was identified as a binding partner of a putative p53 protein kinase, PRPK.
This proved to be an excellent choice, as Downey et al. (2006) provide evidence that Yml036, which they rename Cgi121, is part of a previously unidentified conserved protein complex that not only affects telomere capping but is also required for the maintenance of normal telomere length. They begin by demonstrating that the yeast ortholog of PRPK, a poorly characterized kinase known as Bud32, interacts with Cgi121. Significantly, deletion of BUD32 suppresses the cdc13-1 mutation even more strongly than does deletion of CGI121. Using a TAP-tag purification approach, they then show that Cgi121 and Bud32 are part of a larger protein complex containing Gon7 (a small protein of unknown function) and Kae1 (a putative endopeptidase). Significantly, single deletions of CGI121, BUD32, or GON7 all result in a short telomere phenotype, where the telomeric DNA repeat sequence (TG 1-3 ), normally 300-400 bp in length, is reduced to as little as ?100 bp (when BUD32 is deleted). Interestingly, KAE1 is an essential gene and thus cannot be tested. Double mutants do not display additional shortening, indicating that these proteins act together to promote telomere elongation, in a complex that the authors name "KEOPS," for kinase, putative endopeptidase, and other proteins of small size. The short telomere phenotype of KEOPS mutants places these proteins in a class that includes the yeast ATM kinase-like Tel1, the conserved MRX (Mre11, Rad50, Xrs2) complex, and the Yku70/80 heterodimer. By contrast, deletion of these other genes does not suppress the loss of cdc13-1, and in fact, YKU70 deletion seriously compromises growth when combined with cdc13-1.
So, why do KEOPS mutants suppress the cdc13-1 mutation? Here, Downey et al. (2006) provide a very clear-cut answer. They show that the CGI121 deletion strongly suppresses the appearance of single-stranded DNA at telomeres in cdc13-1 mutants. Deletion of the Bud32 kinase presumably has the same effect, though this has not been tested. The conclusion is that the KEOPS complex in some manner promotes the uncapping and/or 5′ end resection of telomeres that occurs in cdc13-1 mutants, perhaps by altering telomere structure in some way or by directly promoting the action of Exo1 or another exonuclease. Downey et al. (2006) , however, do not dwell on this point but instead perform a series of experiments to get at the question as to why KEOPS mutants have short telomeres. After all, this is the key phenotype of KEOPS mutants, which appear to have no effect on telomere capping in CDC13-positive cells. To address this question, they first exploit a system developed by Kolodner and colleagues to examine a process called "telomere healing," whereby telomerase acts at accidental DNA double-strand breaks (DSBs) to generate a novel telomere (Myung et al., 2001 ). Mutation of PIF1 had previously been shown to cause a dramatic increase in spontaneous telomere healing events, consistent with the observation that the Pif1 helicase acts to remove telomerase from native telomeres. Downey et al. (2006) show that this increase in telomere formation seen in pif1 mutant cells is abolished by deletion of BUD32, suggesting that the KEOPS complex may either regulate telomerase recruitment or telomerase activity at DSBs.
To dissect this process in more detail, and in cells containing the Pif1 helicase, the authors turned to an experimental system recently described by our own laboratory that quantifies telomere formation at an induced DSB. In this system it was shown that tethering the telomerase accessory protein Est1 to the break, in the form of a fusion with the Gal4 DNA binding protein (GBD), strongly promotes telomere formation. Strikingly, cells lacking BUD32 are defective in this GBD-Est1 assay, and the authors suggest that this is evidence "that Bud32 is not involved in the series of events that lead to Est1 recruitment," namely the resection of DNA ends and the binding of Cdc13 or Rpa1. Although the results are certainly consistent with this idea, other interpretations are possible. For example, the recruitment of telomerase by GBD-Est1 might initiate the process of telomere formation, but its successful completion might require the full set of reactions (which include resection, followed by Cdc13 and Rpa1 binding) that occur during "normal" telomerase replication (Figure 1) .
Perhaps with this caveat in mind, the authors then examined the effect of KEOPS (specifically Bud32) on the elongation of telomeres that occurs when telomerase subunits are artificially recruited to native telomeres. For these experiments they took advantage of observations made by Lundblad and colleagues (Evans and Lundblad, 1999) , who showed that fusions of either Est1 or Est2 (the catalytic core of telomerase) to Cdc13 lead to excessive telomeres elongation, probably because they short-circuit the normal recruitment process. Notably, Downey et al. (2006) find that cells lacking Bud32 are highly defective in telomere elongation that is triggered by Cdc13-Est hybrids. Again, this is consistent with the idea that Bud32 acts at some step after telomerase recruitment. They point out that the failure of Cdc13-Est1 hybrids to promote telomere elongation in bud32 mutant cells is reminiscent of the failure of Cdc13-Est2 to promote elongation in cells lacking EST1. This may reflect a poorly understood function of Est1 in either activation of telomerase or promoting its access to the telomere 3′ end. The authors propose that KEOPS plays a direct role in this still mysterious function of Est1 ( Figure 1A) . In further support of this notion they show that est1 bud32 double mutants are no more defective in Cdc13-Est2 over-elongation than the est1 single mutant.
Another way to think about these results takes into account the fact that Cdc13 binding itself is believed to require 5′ end resection to generate a 3′ G/T-rich single-strand DNA overhang. In the absence of normal resection it is possible that neither native Cdc13 nor Cdc13-Est hybrids will have sufficient access to the telomere end to promote elongation. Thus, an alternative scenario is that the defect in telomere length that is observed in KEOPS mutants is due to a defect in resection, which leads to reduced binding of Cdc13 and Rpa1, and ultimately reduced recruitment of Est1 and Est2 ( Figure 1B) . The formation of TG-strand overhangs late in S phase is thought to be a critical step in telomere maintenance, but the mechanism underlying this process and its regulation are still very much unclear. Although the MRX (Mre11, Rad50, Xrs2) complex plays some role (Larrivee et al., 2004; Takata et al., 2005) , the nuclease activity of Mre11 is not required. Furthermore, overhang length still increases during S phase in the absence of MRX, as does Cdc13 binding (Takata et al., 2005; Tsukamoto et al., 2001; Larrivee et al., 2004) . Although it is untested whether KEOPS plays a key role in activating or controlling the resection process at telomeres, such a role might explain why KEOPS mutants fail to generate the extensive, pathological resection that leads to cellcycle arrest in cdc13-1 mutants. A more detailed analysis of telomere replication in KEOPS mutants, as well as identification of KEOPS targets (considering both its kinase and putative endopeptidase activities), will certainly help to distinguish between these and other models.
In summary, Downey et al. (2006) have discovered a new and apparently highly conserved regulator of telomere replication and capping. This advance emphasizes the tight linkage between these two processes. One theme that emerges from this remarkable work is that either the access to the telomere by telomerase or its activation at the chromosome end involves a structural transition at the telomere that generates a tran- The open complex is a state that allows telomerase and other proteins to have physical access to the DNA end of the telomere. Est1 is recruited to telomeres through an interaction with Cdc13 (Evans and Lundblad, 1999) and/or Rpa1 (Schramke et al., 2004) . (B) Alternatively, KEOPS could promote resection and the formation of TG overhangs at telomeres in S phase (the proposed "open state" of replicating telomeres), which would then lead to Cdc13-and Rpa1-dependent telomerase recruitment in wild-type cells and to runaway resection in cdc13-1 cells (indicated by the orange figure, which consists, at least in part, of Exo1), with ensuing checkpoint activation. sient uncapped state. In mammalian cells, capping is carried out by a protein complex, dubbed "shelterin" (de Lange, 2005) , which may act in part by promoting the formation of a protective structure, the T loop, in which the chromosome 3′ single-strand terminus is folded back and buried in a more internal sequence. Thus, it will be interesting to see if and how mammalian KEOPS (whose existence is still hypothetical) impinges upon shelterin or other telomeric factors in mammalian cells.
This elegant study is certain to lead to additional important insights into both the nature of the telomere cap and the mechanism of telomerase regulation and highlights the close relationship between the two that was first revealed by studies of Cdc13 (Nugent et al., 1996) . The discovery of KEOPS as a new key player in telomere function is an exciting development that underscores our still incomplete understanding of telomere biology, as well as the utility of the budding yeast S. cerevisiae, which continues to provide new genes with which to build models.
Life requires us to make decisions every day. Usually, our first step is to take the information available and process it ourselves. However, when crucial decisions arise, we often ask advice from friends, family, and colleagues. Many times we get varying, even opposing, advice and we are left with the challenge of weighing these suggestions with our own perspective of the situation (or with our own instincts).
Cells have this problem too. They often need to respond simultaneously to multiple external signals, many of which are contradictory and promote opposite cellular events. For example, different cytokines that activate or inhibit cell survival can compete with each other in the context of tissue homeostasis. The response may also differ from cell to cell, depending on the cell's own internal state. How do cells cope with extracellular signals that antagonize each other, and how does the pre-existing state of the cell affect the final outcome?
In this issue of Cell, Peter Sorger and colleagues (Janes et al., 2006) study cellular responses to opposing extracellular signals using highthroughput time-resolved measurements of multiple signaling proteins. The results are surprising: processing an extracellular signal is not only an intracellular event but also involves the release of and response to additional secreted factors with antagonistic functions. This finding brings to the forefront the importance of autocrine signaling in determining cellular conference call: external feedback Affects cell-fate decisions
